Meropenem: all 68 studies that test it

Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.

• THE ROLE OF PANCREATIC STONE PROTEIN (PSP) AND PSP-GUIDED EARLY MEROPENEM TREATMENT TO MITIGATE SEPSIS RISK AT THE EMERGENCY DEPARTMENT: THE PROMISE DOUBLE BLIND, PHASE III, RANDOMIZED CONTROLLED CLINICAL TRIALRecruitingNCT07813767Phase 3
• COMPARISON OF SINGLE VERSUS COMBINATION DRUG THERAPY IN EXTENSIVELY DRUG RESISTANT SALMONELLA TYPHI IN TERMS OF TIME TO DEFERVESCENCENot yet recruitingNCT07641348Not applicable
• The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)RecruitingNCT07556107Phase 4
• A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABPRecruitingNCT07327619Phase 3
• Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae InfectionsRecruitingNCT07089186Phase 3
• Optimising TREATment for Severe Gram-Negative Bacterial InfectionsRecruitingNCT07004049Phase 4
• A Study to Assess How Vaborem® is Taking up in the Body and Tolerated in Paediatric Patients With Gram Negative Infections, Including But Not Restricted to Complicated Urinary Tract InfectionsRecruitingNCT06828848Phase 2
• Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAINot yet recruitingNCT06633718Phase 3
• Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With SepsisRecruitingNCT06184659Phase 4
• A Pilot Study for Optimizing Meropenem Administration in the ICURecruitingNCT05578586Not applicable
• A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE)CompletedNCT01970371Phase 3Results posted
• Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)CompletedNCT01597973Phase 3Results posted
• Clinical Trials to Reduce the Risk of Antimicrobial ResistanceTerminatedNCT01570192Phase 2Results posted
• Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) ChildrenCompletedNCT01429259Phase 4Results posted
• A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal InfectionsTerminatedNCT01110382Phase 3Results posted
• Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal InfectionsCompletedNCT00621192Phase 1/2Results posted
• Colistin and Meropenem Versus Amikacin and Meropenem for MDR Gram Negative Bacteria Regarding Efficacy and Safety.Active, not recruitingNCT07694700Phase 4
• EFFICACY OF PROLONGED INFUSION MEROPENEM IN CRITICALLY ILL PAEDIATRIC INTENSIVE CARE PATIENTSCompletedNCT07122596Phase 4
• Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without PeritonitisCompletedNCT07113574Phase 2/3
• Comparison Between Carbapenems and Noncarbapenem Beta-lactam Antibiotics in Septic Burn PatientsActive, not recruitingNCT07096310Phase 1/2
• Evaluation of the Concentration of ANT3310 and Meropenem in the Lung in Healthy Adult ParticipantsCompletedNCT06916156Phase 1
• Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired SubjectsCompletedNCT06527677Phase 1
• FiH Study to Assess Safety and PK of SAD and MAD of ANT3310 Alone and in Combination With Meropenem in Healthy SubjectsCompletedNCT05905913Phase 1
• Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary TuberculosisCompletedNCT05896930Phase 2
• Antimicrobial Revision in Persistent Febrile NeutropeniaWithdrawnNCT05784844Phase 4
• Multicentral Preventive Antibiotics With Cystectomy Within Enhanced Recovery After SurgeryStatus unknownNCT05392634Phase 3
• Study of the Safety and Pharmacokinetics of KSP-1007 Alone and Coadministered With Meropenem in Healthy SubjectsCompletedNCT05226923Phase 1
• Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to CarbapenemsTerminatedNCT04876430Phase 2/3
• Antibiotics Continuous Infusion at HomeStatus unknownNCT04816968Phase 1
• Antidote for Valproic Acid Toxicity: a New Indication for Meropenem Antibiotic.Status unknownNCT04671589Phase 4
• Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTBCompletedNCT04629378Phase 2
• Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella PneumoniaeStatus unknownNCT04489459Phase 4
• Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic PatientsStatus unknownNCT04233996Phase 4
• Non-operative Treatment of Acute Non-perforated AppendicitisCompletedNCT04030741Phase 2/3
• Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing EnterobacteriaceaeSuspendedNCT03891433Phase 4
• suPAR to Guide Antibiotics in Emergency DepartmentStatus unknownNCT03717350Phase 2/3
• Efficacy and Pharmacokinetics of Meropenem in Severe Septic PatientsCompletedNCT03645668Phase 4
• Bolus Versus Continuous Infusion of MeropenemCompletedNCT03452839Phase 4
• A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract InfectionCompletedNCT03174795Phase 1
• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7079901 and the Combination of RO7079901 With Meropenem in Adult Healthy VolunteersCompletedNCT02972255Phase 1
• LC-MS/MS Based Method Development for the Monitoring of Antibiotic Concentrations in Sputum of Cystic Fibrosis PatientsTerminatedNCT02840136Not applicable
• PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic ShockCompletedNCT02820987Phase 3
• The Pharmacodynamics of Meropenem in Patient With Ventilator-associated PneumoniaCompletedNCT02615041Phase 4
• Meropenem Penetration Across BBB in Patients With CNS Infection and Optimization of Meropenem TreatmentCompletedNCT02506686Phase 4
• Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile NeutropeniaStatus unknownNCT02463747Phase 4
• Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary TuberculosisCompletedNCT02349841Phase 2
• Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem During the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care UnitsCompletedNCT02213796Phase 4
• Comparing the Outcome in Patients of Acute Pancreatitis, With and Without Prophylactic AntibioticsCompletedNCT02212392Phase 1/2
• Bacterial Load Guided Therapy for Severe Bronchiectasis ExacerbationsCompletedNCT02047773Phase 4
• Multi-center Clinical Study of Early Antibios of Severe Acute PancreatitisStatus unknownNCT01992198Phase 4
• Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus MeropenemCompletedNCT01732250Phase 4
• Eradication of Gut MicrobiotaCompletedNCT01633762Early Phase 1
• Conservative Treatment of Acute Appendicitis in ChildrenCompletedNCT01572558Not applicable
• Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age With Probable and Confirmed MeningitisCompletedNCT01554124Phase 1/2
• Efficacy, Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days With Clinical or Confirmed Late-onset SepsisCompletedNCT01551394Phase 3
• Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial PeritonitisTerminatedNCT01455246Phase 2/3
• Pharmacokinetic Study of Extended Infusion Meropenem in Adult Cystic Fibrosis PatientsTerminatedNCT01158937Not applicable
• Duration of Antibiotics in Infective Exacerbations of Cystic FibrosisStatus unknownNCT01044719Phase 4
• A Study of Meropenem Standard 30 Minute Infusion Versus Prolonged 3 Hour Infusion in Intensive Care Unit (ICU) PatientsCompletedNCT00891423Not applicable
• Complicated Skin and Skin Structure InfectionsCompletedNCT00619710Phase 3
• A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe MelioidosisStatus unknownNCT00579956Not applicable
• Comparison of Two Antibiotic Regimen (Meropenem Versus Meropenem+Moxifloxacin)in the Treatment of Severe Sepsis and Septic ShockCompletedNCT00534287Phase 3
• Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU PatientsCompletedNCT00410527Phase 4
• Evaluation of Pancreatic Tissue Penetration of Meronem® in the Prophylaxis of Septic Complications in Severe PancreatitisCompletedNCT00318994Phase 4
• Pharmacoeconomic Analysis of First Line Meropenem Versus Standard Antibiotic Treatment in Seriously Infected Secondary Nosocomial Sepsis Syndrome Patients.CompletedNCT00318552Phase 4
• Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICUTerminatedNCT00307099Phase 3
• Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)CompletedNCT00153634Not applicable
• A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has DiedCompletedNCT00061438Phase 4

← Meropenem overview